PT3256605T - Deteção de mutações para rastreio de cancro e análise fetal - Google Patents

Deteção de mutações para rastreio de cancro e análise fetal

Info

Publication number
PT3256605T
PT3256605T PT167487453T PT16748745T PT3256605T PT 3256605 T PT3256605 T PT 3256605T PT 167487453 T PT167487453 T PT 167487453T PT 16748745 T PT16748745 T PT 16748745T PT 3256605 T PT3256605 T PT 3256605T
Authority
PT
Portugal
Prior art keywords
cancer screening
detecting mutations
fetal analysis
fetal
analysis
Prior art date
Application number
PT167487453T
Other languages
English (en)
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Publication of PT3256605T publication Critical patent/PT3256605T/pt

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50Mutagenesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT167487453T 2015-02-10 2016-02-14 Deteção de mutações para rastreio de cancro e análise fetal PT3256605T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562114471P 2015-02-10 2015-02-10
US201562271196P 2015-12-22 2015-12-22

Publications (1)

Publication Number Publication Date
PT3256605T true PT3256605T (pt) 2022-03-17

Family

ID=56615337

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167487453T PT3256605T (pt) 2015-02-10 2016-02-14 Deteção de mutações para rastreio de cancro e análise fetal

Country Status (15)

Country Link
US (3) US10240209B2 (pt)
EP (2) EP4012715A1 (pt)
JP (3) JP6829211B2 (pt)
KR (1) KR20170125044A (pt)
CN (2) CN107771221B (pt)
AU (2) AU2016218631B2 (pt)
CA (1) CA2976303A1 (pt)
DK (1) DK3256605T3 (pt)
ES (1) ES2908347T3 (pt)
HK (2) HK1244515A1 (pt)
HU (1) HUE058263T2 (pt)
PT (1) PT3256605T (pt)
SG (1) SG11201706529TA (pt)
TW (3) TWI817187B (pt)
WO (1) WO2016127944A1 (pt)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
CN110872617A (zh) 2012-09-04 2020-03-10 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
JP6410726B2 (ja) 2012-12-10 2018-10-24 レゾリューション バイオサイエンス, インコーポレイテッド 標的化ゲノム解析のための方法
WO2015100427A1 (en) 2013-12-28 2015-07-02 Guardant Health, Inc. Methods and systems for detecting genetic variants
TWI813141B (zh) 2014-07-18 2023-08-21 香港中文大學 Dna混合物中之組織甲基化模式分析
KR102441391B1 (ko) 2014-07-25 2022-09-07 유니버시티 오브 워싱톤 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
CA2976303A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
CN114999567A (zh) 2015-07-23 2022-09-02 香港中文大学 游离dna的片段化模式的分析
RU2018121254A (ru) 2015-11-11 2019-12-16 Резолюшн Байосайенс, Инк. Высокоэффективное построение библиотек днк
CN117174167A (zh) 2015-12-17 2023-12-05 夸登特健康公司 通过分析无细胞dna确定肿瘤基因拷贝数的方法
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
WO2017153848A1 (en) * 2016-03-10 2017-09-14 Genomic Vision Method of curvilinear signal detection and analysis and associated platform
CN116445593A (zh) 2016-08-10 2023-07-18 格里尔公司 测定一生物样品的一甲基化图谱的方法
KR102505122B1 (ko) 2016-08-25 2023-03-08 레졸루션 바이오사이언스, 인크. Dna 샘플 중 게놈 카피 변화의 검출을 위한 방법
KR102344635B1 (ko) 2016-09-30 2021-12-31 가던트 헬쓰, 인크. 무세포 핵산의 다중-해상도 분석 방법
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
WO2018081130A1 (en) * 2016-10-24 2018-05-03 The Chinese University Of Hong Kong Methods and systems for tumor detection
CA3039685A1 (en) 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
WO2018119216A1 (en) * 2016-12-21 2018-06-28 The Regents Of The University Of California Deconvolution and detection of rare dna in plasma
TW202348802A (zh) 2017-01-25 2023-12-16 香港中文大學 使用核酸片段之診斷應用
EP3366780B1 (en) * 2017-02-23 2020-05-06 Siemens Healthcare GmbH Single-molecule sequence and high sensitivity methylation analysis for tissue-specific analysis
IT201700045353A1 (it) * 2017-04-26 2018-10-26 Bioscience Services S R L Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi
EP3625341A4 (en) 2017-05-16 2021-05-19 Guardant Health, Inc. IDENTIFICATION OF SOMATIC ORIGIN OR GERMINAL LINE OF CELLLESS DNA
US10081829B1 (en) 2017-06-13 2018-09-25 Genetics Research, Llc Detection of targeted sequence regions
US10636512B2 (en) 2017-07-14 2020-04-28 Cofactor Genomics, Inc. Immuno-oncology applications using next generation sequencing
EP3431610A1 (en) * 2017-07-19 2019-01-23 Noscendo GmbH Methods and devices for nucleic acid-based real-time determination of disease states
EP3658684B1 (en) 2017-07-26 2023-08-30 The Chinese University Of Hong Kong Enhancement of cancer screening using cell-free viral nucleic acids
CN111164701A (zh) * 2017-10-06 2020-05-15 格瑞尔公司 针对靶标定序的定点噪声模型
CA3079253A1 (en) * 2017-11-03 2019-05-09 Guardant Health, Inc. Normalizing tumor mutation burden
KR20200093438A (ko) * 2017-12-01 2020-08-05 일루미나, 인코포레이티드 체성 돌연변이 클론형성능을 결정하기 위한 방법 및 시스템
WO2019140226A1 (en) * 2018-01-12 2019-07-18 Grail, Inc. Methods for analyzing viral nucleic acid
DE202019005627U1 (de) 2018-04-02 2021-05-31 Grail, Inc. Methylierungsmarker und gezielte Methylierungssondenpanels
WO2019200398A1 (en) * 2018-04-13 2019-10-17 Dana-Farber Cancer Institute, Inc. Ultra-sensitive detection of cancer by algorithmic analysis
US20210104297A1 (en) * 2018-04-16 2021-04-08 Grail, Inc. Systems and methods for determining tumor fraction in cell-free nucleic acid
TW202012639A (zh) * 2018-04-24 2020-04-01 美商格瑞爾公司 使用病原體核酸負荷確定個體是否患有癌症病況的系統及方法
CN108900319B (zh) * 2018-05-30 2021-05-25 北京百度网讯科技有限公司 故障检测方法和装置
SG11202100344WA (en) * 2018-07-23 2021-02-25 Guardant Health Inc Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage
WO2020023671A1 (en) * 2018-07-24 2020-01-30 Protocol Intelligence, Inc. Methods and systems for treating cancer and predicting and optimizing treatment outcomes in individual cancer patients
WO2020023744A1 (en) * 2018-07-26 2020-01-30 Lexent Bio, Inc. Multiple sequencing using a single flow cell
CN109022619A (zh) * 2018-08-27 2018-12-18 郑州安图生物工程股份有限公司 一种用于检测人类疱疹病毒4型的试剂盒
CN113286881A (zh) 2018-09-27 2021-08-20 格里尔公司 甲基化标记和标靶甲基化探针板
ES2968457T3 (es) * 2018-12-19 2024-05-09 Univ Hong Kong Chinese Características de los extremos del ADN extracelular circulante
JP2022519045A (ja) 2019-01-31 2022-03-18 ガーダント ヘルス, インコーポレイテッド 無細胞dnaを単離するための組成物および方法
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
BR112021022879A2 (pt) * 2019-05-20 2022-03-22 Found Medicine Inc Sistemas e métodos para avaliação de fração tumoral
JP7506060B2 (ja) * 2019-06-03 2024-06-25 イルミナ インコーポレイテッド 検出限界ベースの品質管理メトリック
KR20220064951A (ko) * 2019-06-21 2022-05-19 쿠퍼서지컬, 인코퍼레이션. 인간 배아에서의 복제 수 변이의 확인을 위한 단일 뉴클레오티드 변이의 밀도를 사용하는 시스템 및 방법(systems and methods for using density of single nucleotide variations for the verification of copy number variations in human embryos)
EP4004238A1 (en) * 2019-07-23 2022-06-01 Grail, LLC Systems and methods for determining tumor fraction
EP4020484A4 (en) * 2019-08-19 2023-08-30 Green Cross Genome Corporation METHOD FOR DETECTING A CHROMOSOME ABNORMALITY USING INFORMATION CONCERNING THE DISTANCE BETWEEN NUCLEIC ACID FRAGMENTS
WO2021137770A1 (en) * 2019-12-30 2021-07-08 Geneton S.R.O. Method for fetal fraction estimation based on detection and interpretation of single nucleotide variants
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
KR20230125790A (ko) * 2020-12-08 2023-08-29 더 차이니즈 유니버시티 오브 홍콩 비뇨기 및 기타 dna의 특징을 사용하는 방법
CN113628683B (zh) * 2021-08-24 2024-04-09 慧算医疗科技(上海)有限公司 一种高通量测序突变检测方法、设备、装置及可读存储介质
WO2023129983A1 (en) * 2021-12-29 2023-07-06 AiOnco, Inc. Processing encrypted data for artificial intelligence-based analysis
CN114582429B (zh) * 2022-03-03 2023-06-13 四川大学 基于层次注意力神经网络的结核分枝杆菌耐药性预测方法及装置
KR102491322B1 (ko) * 2022-03-29 2023-01-27 주식회사 아이엠비디엑스 암 진단을 위한 다중 분석 예측 모델의 제조 방법
WO2023225659A2 (en) * 2022-05-19 2023-11-23 Personalis, Inc. Methods and system for using methylation data for disease detection and quantification
CN115394358B (zh) * 2022-08-31 2023-05-12 西安理工大学 基于深度学习的单细胞测序基因表达数据插补方法和系统
CN117153253B (zh) * 2022-09-09 2024-05-07 南京金斯瑞生物科技有限公司 一种设计人源化抗体序列的方法
CN115424666B (zh) * 2022-09-13 2023-07-11 江苏先声医学诊断有限公司 一种基于全基因组重亚硫酸盐测序数据筛选泛癌早筛分子标志物的方法及系统

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20013527A3 (cs) 1999-04-02 2002-10-16 Corixa Corporation Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic
US20030219765A1 (en) 2000-03-23 2003-11-27 Jose Costa Methods for evaluating cancer risk
JP2005514956A (ja) * 2002-01-18 2005-05-26 ジェンザイム・コーポレーション 胎児dnaの検出および対立遺伝子の定量化のための方法
US7704687B2 (en) 2002-11-15 2010-04-27 The Johns Hopkins University Digital karyotyping
US8394582B2 (en) 2003-03-05 2013-03-12 Genetic Technologies, Inc Identification of fetal DNA and fetal cell markers in maternal plasma or serum
PL201608B1 (pl) 2003-06-13 2009-04-30 Cezary Cybulski Sposób i zestaw do wykrywania wysokiej genetycznie uwarunkowanej predyspozycji do raka prostaty oraz zastosowanie zmiany germinalnej w obrębie genu NBS1
ATE435301T1 (de) 2003-10-16 2009-07-15 Sequenom Inc Nicht invasiver nachweis fötaler genetischer merkmale
EP1751306A1 (en) 2004-04-30 2007-02-14 Yale University Methods and compositions for cancer diagnosis
US20070122823A1 (en) 2005-09-01 2007-05-31 Bianchi Diana W Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis
EP2423334A3 (en) 2006-02-02 2012-04-18 The Board of Trustees of The Leland Stanford Junior University Non-invasive fetal genetic screening by digital analysis
SI1996728T1 (sl) 2006-02-28 2011-10-28 Univ Louisville Res Found Prepoznavanje kromosomskih nenormalnosti pri zarodku s pomočjo dvojnih mononukleotidnih polimorfizmov
WO2008024009A1 (fr) 2006-08-15 2008-02-28 Institut Molekulyarnoi Genetiki Rossiiskoi Akademii Nauk (Img Ran) Niveau de transcription du gène timp3 utilisé en tant que marqueur servant à diagnostiquer le cancer du poumon non à petites cellules
EP2535425A1 (en) 2007-05-25 2012-12-19 Decode Genetics EHF. Variantes génétiques sur les chr 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein
EA028642B1 (ru) 2007-07-23 2017-12-29 Те Чайниз Юниверсити Ов Гонгконг Способ пренатальной диагностики фетальной хромосомной анэуплоидии
US20090053719A1 (en) 2007-08-03 2009-02-26 The Chinese University Of Hong Kong Analysis of nucleic acids by digital pcr
US20100041048A1 (en) 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
EP3751005A3 (en) 2008-09-20 2021-02-24 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US20100136560A1 (en) 2008-12-02 2010-06-03 The Johns Hopkins University Integrated Analyses of Breast and Colorectal Cancers
EP2414540A1 (en) 2009-03-31 2012-02-08 Oridis Biomarkers GmbH Method for diagnosis of cancer and monitoring of cancer treatments
EP2483426A4 (en) 2009-10-02 2013-04-10 Ct For Addiction And Mental Health METHOD FOR ANALYZING METHYLATION PROFILES OF ACELLULAR CIRCULATING DNA IN BODY FLUIDS
WO2011053790A2 (en) 2009-10-30 2011-05-05 Fluidigm Corporation Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis
CN102770558B (zh) * 2009-11-05 2016-04-06 香港中文大学 由母本生物样品进行胎儿基因组的分析
EA034241B1 (ru) 2009-11-06 2020-01-21 Те Чайниз Юниверсити Ов Гонконг Способ пренатальной диагностики дисбаланса последовательности
GB0922006D0 (en) 2009-12-17 2010-02-03 Genome Res Ltd Diagnostic
EP2513341B1 (en) 2010-01-19 2017-04-12 Verinata Health, Inc Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
WO2011090558A1 (en) 2010-01-19 2011-07-28 Verinata Health, Inc. Simultaneous determination of aneuploidy and fetal fraction
US20130210645A1 (en) 2010-02-18 2013-08-15 The Johns Hopkins University Personalized tumor biomarkers
EP2426217A1 (en) 2010-09-03 2012-03-07 Centre National de la Recherche Scientifique (CNRS) Analytical methods for cell free nucleic acids and applications
SG10202008532PA (en) 2010-11-30 2020-10-29 Univ Hong Kong Chinese Detection of genetic or molecular aberrations associated with cancer
EP2563937A1 (en) 2011-07-26 2013-03-06 Verinata Health, Inc Method for determining the presence or absence of different aneuploidies in a sample
AU2012318371B2 (en) * 2011-10-06 2018-03-22 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10214775B2 (en) 2011-12-07 2019-02-26 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
EP2825675B1 (en) 2012-03-13 2017-12-27 Patel, Abhijit Ajit Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing
CN104380395A (zh) 2012-05-31 2015-02-25 住友电气工业株式会社 氧化物超导薄膜及其制造方法
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
CN110872617A (zh) * 2012-09-04 2020-03-10 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
KR102390711B1 (ko) * 2012-09-20 2022-04-26 더 차이니즈 유니버시티 오브 홍콩 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
CA2902207A1 (en) * 2013-02-21 2014-08-28 Toma Biosciences, Inc. Methods, compositions, and kits for nucleic acid analysis
AU2014233373B2 (en) 2013-03-15 2019-10-24 Verinata Health, Inc. Generating cell-free DNA libraries directly from blood
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
US10262755B2 (en) * 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US20160002717A1 (en) 2014-07-02 2016-01-07 Boreal Genomics, Inc. Determining mutation burden in circulating cell-free nucleic acid and associated risk of disease
KR102441391B1 (ko) 2014-07-25 2022-09-07 유니버시티 오브 워싱톤 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법
WO2016085876A1 (en) 2014-11-25 2016-06-02 The Broad Institute Inc. Clonal haematopoiesis
AU2015357573B2 (en) 2014-12-05 2022-04-07 Foundation Medicine, Inc. Multigene analysis of tumor samples
EP3240911B1 (en) 2014-12-31 2020-08-26 Guardant Health, Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
CA2976303A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
CA2980078C (en) 2015-03-16 2024-03-12 Personal Genome Diagnostics Inc. Systems and methods for analyzing nucleic acid

Also Published As

Publication number Publication date
JP7168247B2 (ja) 2022-11-09
JP6829211B2 (ja) 2021-02-10
TW202400808A (zh) 2024-01-01
DK3256605T3 (da) 2022-03-14
AU2022203114A1 (en) 2022-05-26
ES2908347T3 (es) 2022-04-28
HK1244515A1 (zh) 2018-08-10
TW201700732A (zh) 2017-01-01
US20170073774A1 (en) 2017-03-16
EP3256605B1 (en) 2022-02-09
JP2018512048A (ja) 2018-05-10
EP3256605A1 (en) 2017-12-20
HUE058263T2 (hu) 2022-07-28
CN107771221B (zh) 2021-11-02
EP3256605A4 (en) 2018-10-17
TWI817187B (zh) 2023-10-01
EP4012715A1 (en) 2022-06-15
SG11201706529TA (en) 2017-09-28
CN107771221A (zh) 2018-03-06
US20220127683A1 (en) 2022-04-28
WO2016127944A1 (en) 2016-08-18
TW202146657A (zh) 2021-12-16
JP2022185149A (ja) 2022-12-13
US10240209B2 (en) 2019-03-26
US11168370B2 (en) 2021-11-09
HK1251018A1 (zh) 2019-01-18
AU2016218631B2 (en) 2022-03-10
US20190153541A1 (en) 2019-05-23
CA2976303A1 (en) 2016-08-18
TWI740817B (zh) 2021-10-01
JP2021061861A (ja) 2021-04-22
AU2016218631A1 (en) 2017-08-17
CN113957124A (zh) 2022-01-21
KR20170125044A (ko) 2017-11-13

Similar Documents

Publication Publication Date Title
HK1251018A1 (zh) 用於癌症篩查和胎兒分析的突變檢測
HK1249179A1 (zh) 用於樣品分析的裝置和方法
HK1258539A1 (zh) 微瞬間分析
ZA201706572B (en) Devices and methods for sample analysis
HK1245345A1 (zh) 腫瘤樣本的多基因分析
SG10201408391RA (en) Means and methods for multimodality analysis and processing ofdrilling mud
SG10202001197UA (en) Systems and methods for biological analysis
SG10202103903UA (en) Systems and methods for assessing biological samples
HUE044055T2 (hu) A CPG metiláció kimutatására és a rák diagnosztizálására szolgáló eljárások
IL255346A0 (en) Liposomal preparations for non-invasive prenatal or cancer screening
GB202117492D0 (en) iKnife - cell line identification and analysis
PL3336514T3 (pl) Próbnik do analizy bezpośredniej
PL3336511T3 (pl) Urządzenie do pobierania próbek do bezpośredniej analizy
GB201419814D0 (en) Data traffic processing and analysis
GB201503364D0 (en) A device for receiving and analysing a sample
SG10201601097XA (en) Amplitude-versus-angle analysis for quantitative interpretation
GB2559921B (en) Measuring reagent and analysis device for analyzing biopolymer
HK1209480A1 (en) Gas-phase substance analysis device and gas-phase introduction device
HK1247370A1 (zh) 組織樣本分析技術
SG11201707461YA (en) Sample collection and separation device
HK1250778A1 (zh) 分析物檢測及其方法
HUE045901T2 (hu) Analizáló berendezés víz- és szennyvízanalízishez
GB2558160B (en) Shaker imaging and analysis
HK1231405A1 (zh) 篩選和檢測癌症的方法和組成
GB201611057D0 (en) Spectroscopic analysis